REQUEST A DEMO
Total
USD $0.00
Search more companies

Jhon & David Biotechnology J & D-Biotech S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Jhon & David Biotechnology J & D-Biotech S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Jhon & David Biotechnology J & D-Biotech S.A.S. is an enterprise located in Ecuador, with the main office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on July 26, 2021. The total number of employees is currently 6 (2024). The latest financial highlights indicate a net sales revenue increase of 970.14% in 2025. Over the same period, its total assets grew by 2197.38%. The enterprise’s net profit margin decreased by 0.21% in 2025.

Headquarters
Calle Juan Barrezueta, Oe1-141
Quito; Pichincha;

Contact Details: Purchase the Jhon & David Biotechnology J & D-Biotech S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Jhon & David Biotechnology J & D-Biotech S.A.S. report to view the information.
Registered Capital:
Purchase the Jhon & David Biotechnology J & D-Biotech S.A.S. report to view the information.
Financial Auditors:
Purchase the Jhon & David Biotechnology J & D-Biotech S.A.S. report to view the information.
Incorporation Date:
July 26, 2021
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Jhon & David Biotechnology J & D-Biotech S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
970.14%
Total Operating Revenue
970.14%
Operating Profit
58.03%
EBITDA
80.79%
Net Profit/Loss for the Period
608.05%
Total Assets
2197.38%
Total Equity
548.58%
Operating Profit Margin
-4.56%
Net Profit Margin
-0.21%
Return on Equity (ROE)
7.1%
Quick Ratio
-0.07%
Cash Ratio
-0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?